Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Salivary Glands Tumors × Abiraterone Acetate × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Salivary Glands Tumors 1

Interventions

Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02867852 2021-03-03

SG-ABI14

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Salivary Glands Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡